Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3685-3690

  Sasano, Hironobu ^a   Frost, Andra R ^b   Saitoh, Ryuta ^a   Taniyama, Yousuke ^a   Nagura, Hiroshi ^a   Matsunaga, Gen ^a   Takehana, Koh ^c   Kimura, Michio ^c   Silverberg, Steven G ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c Tohoku Kousai Hospital   (Japan)

Author keywords

Breast; Cell proliferation; Cyclin dependent kinase; Cyclins; Immunohistochemistry

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; CDC2-CDC28 KINASES; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0030856156     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cordon-Cardo C: Mutation of cell cycle regulators-Biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560, 1995.
2. Dutta A, Chandra R, Leiter LM, Lester S: Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proc Natl Acad Sci 92: 5386-5390, 1495.
3. Nurse P: Universal control mechanism in regulating onset of M-phase. Nature 344: 503-508. 1990.
4. Reed SI: The role of p34 kinases in the G1 to S-phase transition. Annu Rev Cell Biol 8: 529-561, 1992.
5. Zukerberg LR, Yang W-I, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A: Cyclin D1 (PPAD1) protein expression expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8: 560-567, 1995.
6. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385, 1994.
7. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP: Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS and MDM2. Cancer Res 54: 4299-4303, 1994.
8. He J, Allen JR, Collins P, Allalunis-Turner MJ, Godbout R, Day RS III, James CD: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54: 5804-5807, 1994.
9. Hartmann WH, Ozello L, Sobin LH eds:Histologicaltyping of breasttumors (ed 2). Geneva, Switzerland, World Health Organization pp. 15-25, 1982.
10. Elston CW, Ellis IO: Pathologic prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.
11. Susano H, Nagura H, Harada N, Goukon Y, Kimura M: Immunolocalization of uromatuse and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530-535, 1944.
12. Sasano H, Miyazaki S, Goukon Y, Nishihira T, Sawai T, Nagura H: Expression of p53 in human esophageal carcinoma: An immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 23: 1238-1243, 1492.
13. Keyomarsi K, Conte D Jr, Toyofuku W, Fox MP: Deregulation of cyclin E in breast cancer. Oncogene 11: 441-450, 1995.
14. Gillett C, Fantl V, Smith R, Fisher CC, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817, 1494.
15. Nielsen NH, Arnerlov C, Emdin SO, Landberg G: Cyclin Eoverexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74: 874-880. 1996.
16. Michalides P, Hageman P, Tinteren van H, Houben L, Wientjens E, Klompmaker R, Peterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73: 728-734, 1996.
17. Lammie GA, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer cells (Cold Spring Harbor) 3: 413-420, 1991.
18. McIntosh GG, Anderson JJ, Milton 1, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TW, Horne CH: Determination ofthe prognosticvalueof cyclin D1 overexpression in breast cancer. Oncogene 11: 885-841, 1995.
19. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116, 1993.
20. Weiß H, Brasching H-P, Bock A, Mauthner F, Peek U: Mitotic rate, DNA distribution, and chromatin in situ sensitivity to heparin in breast cancer. Breast Res Treat 16: 41-50, 1990.
21. Lloveras B, Edgerton S, Thor AD: Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit. Am J Clin Pathol 95: 41-47, 1991.
22. MacDivitt RW, Stone KR, Craig RB, Meyer JS: A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling. Lab Invest 52: 287-241, 1985.
23. Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51: 1879-1886, 1983.